Directory
>
Art Taveras
Art Taveras
Chief Scientific Officer | X4 Pharmaceuticals
United States
Art Taveras
Summary
Art Taveras is a distinguished Chief Scientific Officer at X4 Pharmaceuticals, specializing in the discovery and development of small molecule drugs targeting neurodegeneration, cancer, and metabolic diseases. With a robust background in organic chemistry and extensive leadership experience, he has successfully led over 50 R&D programs, contributing to the development of multiple FDA-approved drugs. His innovative work has resulted in over 130 patents and more than 90 publications, showcasing his significant impact on the pharmaceutical industry. Art's entrepreneurial spirit is evident from founding Transform Therapeutics, where he pioneered new therapeutic classes for cancer treatment. He is passionate about advancing drug discovery through technology transfer and collaboration with global biotech firms. Fluent in the language of science, Art is not only a leader but also a mentor to emerging scientists in the field. His commitment to research excellence continues to drive breakthroughs in biopharmaceuticals.
Art Taveras
Work Experience
Chief Scientific Officer at
X4 Pharmaceuticals
November 2020 - Present
Founder; Served as Chief Scientific Officer, Head of Drug Discovery at
Transform Therapeutics, LLC
May 2015 - November 2020
Chief Scientific Officer at
CRISPR Therapeutics
August 2018 - July 2020
President & Chief Scientific Officer at
ChemPartner
January 2013 - December 2014
Vice President Small Molecules Drug Discovery & CMC Development at
Biogen
January 2007 - January 2013
Vice President Drug Discovery & CMC Development at
Alantos Pharmaceuticals, Inc.
May 2004 - November 2007
Drug Discovery, Sr Scientist to Director D2 Level at
Schering-Plough Research Institute
January 1990 - May 2004
Art Taveras
Education
Boston College - Woods College of Advancing Studies
January 2017 - January 2018
Rensselaer Polytechnic Institute, Doctor Of Philosophy (Ph.D.; Dissertation 1991); M.S. (Magna Cum Laude); B.S. (1986; Cum Laude)
January 1982 - January 1990
Frequently Asked Questions about Art Taveras
What is Art Taveras email address?
Art Taveras's primary email address is ***********@x4pharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Art Taveras work for?
Art Taveras is a Chief Scientific Officer at X4 Pharmaceuticals, a company specializing in Commercial physical research.
Where Art Taveras graduated from?
Art Taveras holds a degree in Advanced Studies from Boston College - Woods College of Advancing Studies.
How can I directly contact Art Taveras?
To contact Art Taveras directly, you can use the email address ***********@x4pharma.com. Complete contact information is available upon registration with Muraena.
Who is Art Taveras?
Art Taveras is a distinguished Chief Scientific Officer at X4 Pharmaceuticals, specializing in the discovery and development of small molecule drugs targeting neurodegeneration, cancer, and metabolic diseases. With a robust background in organic chemistry and extensive leadership experience, he has successfully led over 50 R&D programs, contributing to the development of multiple FDA-approved drugs. His innovative work has resulted in over 130 patents and more than 90 publications, showcasing his significant impact on the pharmaceutical industry. Art's entrepreneurial spirit is evident from founding Transform Therapeutics, where he pioneered new therapeutic classes for cancer treatment. He is passionate about advancing drug discovery through technology transfer and collaboration with global biotech firms. Fluent in the language of science, Art is not only a leader but also a mentor to emerging scientists in the field. His commitment to research excellence continues to drive breakthroughs in biopharmaceuticals.
Art`s contact details
***********@x4pharma.com
Colleagues
Founder, President and CEO
Independent Board Member(Non Executive Director)
Vice President, Commercial Operations
Managing Director, Vienna Research Site
Vice President Clinical Development
Vice President Finance, Corporate Controller
Vice President, US Sales
Vice President, Head of Marketing
Chief Operating Officer
Program Executive and Vice President Program Management